Tandem Diabetes Care, Inc. Increase (Decrease) in Employee Related Liabilities
Tandem Diabetes Care, Inc. (TNDM) reported Increase (Decrease) in Employee Related Liabilities of -$17.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-06
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$2.33M, a 319.92% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$14.74M.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $5.80M, a 4.30% increase year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $12.85M, a 18.50% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $6.00M, a 71.26% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $20.86M, a 303.70% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was $5.17M.
- Tandem Diabetes Care, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was -$12.87M, a 173.96% decline from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 3 month as first filed | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 6 month as first filed | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 9 month as first filed | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$17.07M 10-Q · filed 2026-08-06 | -$11.27M derived: sum of 3 quarters · filed 2026-08-06 | $1.57M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$14.74M 10-Q · filed 2026-05-07 | -$8.95M derived: sum of 2 quarters · filed 2026-05-07 | $3.90M derived: sum of 3 quarters · filed 2026-05-07 | $4.96M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $18.64M derived: sum of 2 quarters · filed 2026-02-19 | $19.70M derived: sum of 3 quarters · filed 2026-08-06 | $6.00M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $12.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.90M derived: sum of 2 quarters · filed 2026-08-06 | $197.00K 10-Q · filed 2025-11-06 | $5.76M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$12.65M 10-Q · filed 2026-08-06 | -$7.09M derived: sum of 3 quarters · filed 2026-08-06 | $8.67M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$13.71M 10-Q · filed 2026-05-07 | -$8.15M derived: sum of 2 quarters · filed 2026-05-07 | $7.61M derived: sum of 3 quarters · filed 2026-05-07 | $8.80M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $5.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $21.32M derived: sum of 2 quarters · filed 2026-02-19 | $22.51M derived: sum of 3 quarters · filed 2026-02-19 | $20.86M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $15.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $16.95M derived: sum of 2 quarters · filed 2025-11-06 | $15.30M 10-Q · filed 2025-11-06 | $14.90M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$462.00K 10-Q · filed 2025-08-06 | -$866.00K derived: sum of 3 quarters · filed 2026-02-19 | $7.42M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | -$1.65M 10-Q · filed 2025-04-30 | -$2.06M derived: sum of 2 quarters · filed 2026-02-19 | $6.22M derived: sum of 3 quarters · filed 2026-02-19 | $3.72M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | -$404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $7.88M derived: sum of 2 quarters · filed 2026-02-19 | $5.38M derived: sum of 3 quarters · filed 2026-02-19 | $5.17M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $8.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $5.78M derived: sum of 2 quarters · filed 2024-11-06 | $5.57M 10-Q · filed 2024-11-06 | -$3.71M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$2.71M 10-Q · filed 2024-08-01 | -$11.99M derived: sum of 3 quarters · filed 2025-02-26 | $546.00K derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | -$210.00K 10-Q · filed 2024-05-02 | -$9.49M derived: sum of 2 quarters · filed 2025-02-26 | $3.05M derived: sum of 3 quarters · filed 2025-02-26 | $220.00K derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | -$9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.26M derived: sum of 2 quarters · filed 2025-02-26 | $430.00K derived: sum of 3 quarters · filed 2025-02-26 | -$12.87M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $12.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $9.71M derived: sum of 2 quarters · filed 2023-11-01 | -$3.58M 10-Q · filed 2023-11-01 | $753.00K derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | -$2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$16.13M 10-Q · filed 2023-08-03 | -$11.79M derived: sum of 3 quarters · filed 2024-02-21 | -$1.04M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | -$13.30M 10-Q · filed 2023-05-03 | -$8.96M derived: sum of 2 quarters · filed 2024-02-21 | $1.78M derived: sum of 3 quarters · filed 2024-02-21 | $5.55M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $15.08M derived: sum of 2 quarters · filed 2024-02-21 | $18.85M derived: sum of 3 quarters · filed 2024-02-21 | $17.40M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $10.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $14.51M derived: sum of 2 quarters · filed 2022-11-02 | $13.06M 10-Q · filed 2022-11-02 | $16.70M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.32M 10-Q · filed 2022-08-03 | $5.95M derived: sum of 3 quarters · filed 2023-02-22 | $10.75M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | -$1.45M 10-Q · filed 2022-05-04 | $2.19M derived: sum of 2 quarters · filed 2023-02-22 | $6.99M derived: sum of 3 quarters · filed 2023-02-22 | $10.14M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $8.43M derived: sum of 2 quarters · filed 2023-02-22 | $11.59M derived: sum of 3 quarters · filed 2023-02-22 | $5.34M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $7.96M derived: sum of 2 quarters · filed 2021-11-03 | $1.70M 10-Q · filed 2021-11-03 | $1.82M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$3.09M 10-Q · filed 2021-08-04 | -$2.98M derived: sum of 3 quarters · filed 2022-02-22 | $1.33M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | -$6.25M 10-Q · filed 2021-05-05 | -$6.14M derived: sum of 2 quarters · filed 2022-02-22 | -$1.83M derived: sum of 3 quarters · filed 2022-02-22 | $5.01M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $4.42M derived: sum of 2 quarters · filed 2022-02-22 | $11.27M derived: sum of 3 quarters · filed 2022-02-22 | $4.29M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.15M derived: sum of 2 quarters · filed 2020-11-05 | $4.17M 10-Q · filed 2020-11-05 | $10.97M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $6.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$140.00K 10-Q · filed 2020-07-30 | $6.66M derived: sum of 3 quarters · filed 2021-02-24 | $10.25M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | -$6.98M 10-Q · filed 2020-04-30 | -$181.00K derived: sum of 2 quarters · filed 2021-02-24 | $3.41M derived: sum of 3 quarters · filed 2021-02-24 | $6.54M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $10.39M derived: sum of 2 quarters · filed 2021-02-24 | $13.52M derived: sum of 3 quarters · filed 2021-02-24 | $9.54M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $6.72M derived: sum of 2 quarters · filed 2019-11-04 | $2.74M 10-Q · filed 2019-11-04 | $5.82M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $3.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$848.00K 10-Q · filed 2019-08-01 | $2.23M derived: sum of 3 quarters · filed 2020-02-24 | $519.00K derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | -$3.98M 10-Q · filed 2019-04-30 | -$902.00K derived: sum of 2 quarters · filed 2020-02-24 | -$2.61M derived: sum of 3 quarters · filed 2020-02-24 | -$1.55M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $1.37M derived: sum of 2 quarters · filed 2020-02-24 | $2.43M derived: sum of 3 quarters · filed 2020-02-24 | $3.87M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | -$1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$650.00K derived: sum of 2 quarters · filed 2018-11-01 | $797.00K 10-Q · filed 2018-11-01 | $444.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $2.51M 10-Q · filed 2018-07-30 | $2.15M derived: sum of 3 quarters · filed 2019-02-26 | $1.74M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $1.45M 10-Q · filed 2018-04-26 | $1.09M derived: sum of 2 quarters · filed 2019-02-26 | $678.00K derived: sum of 3 quarters · filed 2019-02-26 | $2.09M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$769.00K derived: sum of 2 quarters · filed 2019-02-26 | $645.00K derived: sum of 3 quarters · filed 2019-02-26 | -$1.58M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $998.00K derived: sum of 2 quarters · filed 2017-10-26 | -$1.23M 10-Q · filed 2017-10-26 | $682.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | -$809.00K 10-Q · filed 2017-07-27 | $1.10M derived: sum of 3 quarters · filed 2018-03-01 | $2.27M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | -$2.22M 10-Q · filed 2017-04-27 | -$316.00K derived: sum of 2 quarters · filed 2018-03-01 | $861.00K derived: sum of 3 quarters · filed 2018-03-01 | $749.00K derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $3.08M derived: sum of 2 quarters · filed 2018-03-01 | $2.97M derived: sum of 3 quarters · filed 2018-03-01 | $2.04M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $1.06M derived: sum of 2 quarters · filed 2016-11-01 | $132.00K 10-Q · filed 2016-11-01 | $1.49M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | -$112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$1.04M 10-Q · filed 2016-07-28 | $309.00K derived: sum of 3 quarters · filed 2017-03-08 | $3.18M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | -$933.00K 10-Q · filed 2016-04-28 | $421.00K derived: sum of 2 quarters · filed 2017-03-08 | $3.29M derived: sum of 3 quarters · filed 2017-03-08 | $2.21M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $4.22M derived: sum of 2 quarters · filed 2017-03-08 | $3.15M derived: sum of 3 quarters · filed 2017-03-08 | $3.85M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $1.79M derived: sum of 2 quarters · filed 2015-10-29 | $2.49M 10-Q · filed 2015-10-29 | $2.49M 10-Q · filed 2014-11-06 | $3.65M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$378.00K 10-Q · filed 2015-07-30 | -$378.20K 10-Q · filed 2014-07-31 | $776.55K derived: sum of 3 quarters · filed 2016-02-24 | $1.56M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $699.00K 10-Q · filed 2015-04-30 | $698.93K 10-Q · filed 2014-05-06 | $1.85M derived: sum of 2 quarters · filed 2016-02-24 | $2.63M derived: sum of 3 quarters · filed 2016-02-24 | $3.52M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $1.93M derived: sum of 2 quarters · filed 2016-02-24 | $2.82M derived: sum of 3 quarters · filed 2016-02-24 | $3.88M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $780.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.66M derived: sum of 2 quarters · filed 2014-11-06 | $2.73M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $881.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $1.95M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $1.07M 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $979.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |